Home  >  News
News
  CTI BioPharma to get $10 million milestone payment from Teva Pharma for Trisenox,   January 19, 2018
  US FDA accepts for review Pharming's sBLA for Ruconest for prophylaxis of HAE attacks,   January 18, 2018
  US FDA grants priority review status to Novartis' sBLA for Kymriah to treat adults with r/r DLBCL,   January 18, 2018
  Bayer says US FDA report reaffirms safety profile and effectiveness of Xarelto in routine clinical practice,   January 17, 2018
  New Year CPhI Japan report predicts 2018 to be transformative year for Japanese pharma,   January 17, 2018
  US FDA accepts Sandoz BLA for proposed biosimilar adalimumab,   January 17, 2018
  Boehringer Ingelheim receives US FDA approval for Gilotrif to treat patients with EGFR mutation-positive NSCLC,   January 17, 2018
  Nuvo Ireland buys US rights to Resultz from Piedmont Pharma,   January 16, 2018
  Norgine receives Austrian, French, Irish, Italian & Portuguese regulatory approval for Plenvu for bowel cleansing in adults,   January 16, 2018
  US FDA approves Lynparza to treat patients with germline BRCA-mutated metastatic breast cancer,   January 15, 2018
  Cour Pharma receives US FDA fast track status for TIMP-GLIA to treat Celiac disease,   January 13, 2018
  US FDA revises labeling to limit use of opioid cough & cold medicines containing codeine/hydrocodone in children below 18 years,   January 13, 2018
  EMA grants orphan drug status to Pracinostat to treat acute myeloid leukemia,   January 13, 2018
  US FDA warns BD for violations of federal law and marketing modified versions of certain BD Vacutainer blood collection tubes,   January 13, 2018
  US FDA grants orphan drug status to Avadel Pharma's FT 218 for narcolepsy treatment,   January 12, 2018
  US FDA accepts Morphotek's IND application for next-generation Farletuzumab ADC MORAb-202,   January 12, 2018
  AstraZeneca's Fasenra receives European approval for severe eosinophilic asthma,   January 12, 2018
  Sonoma Pharma gets 3 new UAE regulatory approvals,   January 11, 2018
  Roche begins tender offer for all outstanding shares of Ignyta at a price of US$ 27 per share in cash,   January 11, 2018
  Hitachi Healthcare to acquire South Carolina-based VidiStar,   January 11, 2018

 Back
 
duphat_150x60
IPJPI18_150x60en_2018
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |